financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Market Chatter: Merck to Discontinue Zinplava for Clostridioides Difficile Infection
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Merck to Discontinue Zinplava for Clostridioides Difficile Infection
Dec 24, 2024 3:23 AM

06:12 AM EST, 12/24/2024 (MT Newswires) -- Merck ( MRK ) will discontinue its antibody drug, Zinplava, which was approved in 2016 to prevent the recurrence of Clostridioides difficile infections, Reuters reported late Monday, citing the US Food and Drug Administration.

Clostridioides difficile infections, often caused by prolonged antibiotic use, can lead to severe diarrhea and colon inflammation.

The report said that Zinplava will be discontinued effective Jan. 31, though no specific reason for the decision was provided.

Merck ( MRK ) and the US Food and Drug Administration did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Newmont Insider Sold Shares Worth $360,000, According to a Recent SEC Filing
Newmont Insider Sold Shares Worth $360,000, According to a Recent SEC Filing
Jan 14, 2025
04:46 PM EST, 01/14/2025 (MT Newswires) -- Natascha Viljoen, Executive Vice President & COO, on January 10, 2025, sold 9,000 shares in Newmont ( NEM ) for $360,000. Following the Form 4 filing with the SEC, Viljoen has control over a total of 145,967 shares of the company, with 145,967 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1164727/000106299325000767/xslF345X05/form4.xml ...
 Air Products and Chemicals Reports Preliminary Fiscal Q1 Earnings
Air Products and Chemicals Reports Preliminary Fiscal Q1 Earnings
Jan 14, 2025
04:47 PM EST, 01/14/2025 (MT Newswires) -- Air Products and Chemicals ( APD ) reported fiscal Q1 preliminary adjusted earnings late Tuesday of $2.86 per share, up from $2.82 a year earlier. Analysts polled by FactSet expect $2.85. ...
 Impinj Reaffirms Q4 Revenue Guidance; Shares Fall After Hours
Impinj Reaffirms Q4 Revenue Guidance; Shares Fall After Hours
Jan 14, 2025
04:49 PM EST, 01/14/2025 (MT Newswires) -- Impinj ( PI ) said Tuesday it continues to expect Q4 revenue of $91 million to $94 million. Analysts polled by FactSet expect $93 million. The company reaffirmed its Q4 guidance, including adjusted EBITDA of between $13.6 million and $15.1 million. Three analysts surveyed by FactSet expect EBITDA of $15.4 million. Impinj (...
 Liquidia Insider Sold Shares Worth $275,299, According to a Recent SEC Filing
Liquidia Insider Sold Shares Worth $275,299, According to a Recent SEC Filing
Jan 14, 2025
04:45 PM EST, 01/14/2025 (MT Newswires) -- Michael Kaseta, CFO and COO, on January 11, 2025, sold 23,370 shares in Liquidia ( LQDA ) for $275,299. Following the Form 4 filing with the SEC, Kaseta has control over a total of 401,755 shares of the company, with 401,755 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1819576/000110465925003470/xslF345X05/tm253294-3_4seq1.xml ...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved